
Opinion|Videos|January 27, 2025
Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care
Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Depression and Long COVID Outcomes in Women: New Data Analysis
2
Presenting Our February 2026 Theme: Bipolar Disorder
3
Investigational Psilocybin for PTSD and Ongoing Trials
4
Patterns of Propensity: A Review of Heinrichs’ How Psychiatrists Make Decisions
5






